These stocks are experiencing solid breakout in a declining market
These stocks are experiencing solid breakout in a declining market

These stocks are experiencing solid breakout in a declining market

Markets opened flat on the back of poor global cues. We curated a list of stocks experiencing a strong positive breakout in this post.

DSIJ Intelligence Article rating: 3.9

Markets opened flat on the back of poor global cues. We curated a list of stocks experiencing a strong positive breakout in this post.

Watch out for these penny stocks locked in the upper circuit on August 10
Watch out for these penny stocks locked in the upper circuit on August 10

Watch out for these penny stocks locked in the upper circuit on August 10

The barometer index, S&P BSE Sensex declined mere 11 points to trade at 58,841 levels at 10.52 am.

DSIJ Intelligence Article rating: 4.1

Due to mixed sentiments on Wednesday among Asian counterparts, the Indian markets traded on the lower side. Broad-based selling pressure during June 2022 quarterly earnings pulled down the major indices like Sensex and Nifty 50.

Rs 1 lakh invested in these stocks could have returned up to Rs 15 lakh in one year!
Rs 1 lakh invested in these stocks could have returned up to Rs 15 lakh in one year!

Rs 1 lakh invested in these stocks could have returned up to Rs 15 lakh in one year!

S&P BSE Sensex, the barometer index, was up by 248 points or 0.42 per cent to 58,604 at 10.05 am.

DSIJ Intelligence Article rating: 4.0

As trading resumed after the public holiday, the significant equity barometers are trading with modest gains in the early trade. The shares of pharma, healthcare, and private banks rose while those of IT, oil & gas, and real estate fell. Asian stock prices are seen falling this morning.

Watch out on Wednesday for this pharma stock that announced bumper Q1 results and 175 per cent dividends
Watch out on Wednesday for this pharma stock that announced bumper Q1 results and 175 per cent dividends

Watch out on Wednesday for this pharma stock that announced bumper Q1 results and 175 per cent dividends

The company has also announced dividends of Rs 3.5 per share that have a face value of Rs 2 per share with a record date fixed on August 22.

DSIJ Intelligence Article rating: 4.2

The company has also announced dividends of Rs 3.5 per share that have a face value of Rs 2 per share with a record date fixed on August 22.   

Top-performing pharma stocks in July 2022
Top-performing pharma stocks in July 2022

Top-performing pharma stocks in July 2022

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  

DSIJ Intelligence Article rating: 3.7

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  The domestic market is anticipated to increase three times in the next ten years, according to the Indian Economic Survey 2021.

 

Top 10 performing SME IPOs of 2022 that delivered returns up to 716 per cent! Do you own any?
Top 10 performing SME IPOs of 2022 that delivered returns up to 716 per cent! Do you own any?

Top 10 performing SME IPOs of 2022 that delivered returns up to 716 per cent! Do you own any?

Empyrean Cashews is the best performing amongst all as it turned out to be an 8-bagger

DSIJ Intelligence Article rating: 4.0

Herein, David is referred to as the SME IPOs. SME stands for small & medium enterprises and is considered to be the backbone of India’s growing economy.   

Blockbuster results: Net profit of this microcap surged over fourfold; will it hit upper circuit on Wednesday? Know here!
Blockbuster results: Net profit of this microcap surged over fourfold; will it hit upper circuit on Wednesday? Know here!

Blockbuster results: Net profit of this microcap surged over fourfold; will it hit upper circuit on Wednesday? Know here!

Most of the micro-cap or small-cap stocks are unpopular and being so is one of the biggest traits of potential multi-baggers.

DSIJ Intelligence Article rating: 4.1

The company reported much-improved quarterly performance in Q1FY23 by registering astonishing healthy growth in the top-line as well as the bottom line.   

RSS
First18731874187518761878188018811882Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList